1.
Lepr Rev
; 75(1): 97-8, 2004 Mar.
Article
in English
| MEDLINE
| ID: mdl-15072132
Subject(s)
Communicable Disease Control/organization & administration , Leprostatic Agents/therapeutic use , Leprosy/drug therapy , Leprosy/prevention & control , Developing Countries , Female , Health Promotion/organization & administration , Humans , Incidence , Leprosy/mortality , Male , Outcome Assessment, Health Care , Program Development , Program Evaluation , Risk Assessment , Severity of Illness Index , Survival Analysis , Yemen/epidemiology
2.
Int. j. lepr. other mycobact. dis
; 67(2): 150-153, Jun., 1999. tab, graf
Article
in English
| Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: biblio-1226867
ABSTRACT
Leprosy control activities in Yemen are reviewed historically and up to the present time. Since 1983 the World Health Organization's multidrug therapy has been used in the National Leprosy Control Programme. Current activities are carried out in 63 leprosy clinics distributed all over the country and staffed by trained primary health care workers and medical assistants. In Yemen leprosy prevalence has declined from 1400 per 10,000 population in 1990 to 647 in 1997. Over the same period, new case detection rates per 10,000 population increased from 185 to 517. A backlog of leprosy cases continues to transmit the disease in Yemen.
